Annual accounts receivable:
$720.91M-$59.46M(-7.62%)Summary
- As of today (September 7, 2025), CRL annual accounts receivable is $720.91 million, with the most recent change of -$59.46 million (-7.62%) on December 28, 2024.
- During the last 3 years, CRL annual accounts receivable has risen by +$78.03 million (+12.14%).
- CRL annual accounts receivable is now -7.62% below its all-time high of $780.38 million, reached on December 30, 2023.
Performance
CRL Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$767.57M+$10.94M(+1.45%)Summary
- As of today (September 7, 2025), CRL quarterly accounts receivable is $767.57 million, with the most recent change of +$10.94 million (+1.45%) on June 28, 2025.
- Over the past year, CRL quarterly accounts receivable has increased by +$5.35 million (+0.70%).
- CRL quarterly accounts receivable is now -4.13% below its all-time high of $800.65 million, reached on June 1, 2023.
Performance
CRL Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CRL Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.6% | +0.7% |
| 3 y3 years | +12.1% | +2.7% |
| 5 y5 years | +40.3% | +44.1% |
CRL Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.6% | +12.1% | -4.1% | +6.5% |
| 5 y | 5-year | -7.6% | +40.3% | -4.1% | +44.1% |
| alltime | all time | -7.6% | +2120.5% | -4.1% | +1570.5% |
CRL Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $767.57M(+1.4%) |
| Mar 2025 | - | $756.63M(+5.0%) |
| Dec 2024 | $720.91M(-7.6%) | $720.91M(-4.4%) |
| Sep 2024 | - | $754.21M(-1.1%) |
| Jun 2024 | - | $762.22M(-3.1%) |
| Mar 2024 | - | $786.98M(+0.8%) |
| Dec 2023 | $780.38M(+3.7%) | $780.38M(-2.4%) |
| Sep 2023 | - | $799.31M(-0.2%) |
| Jun 2023 | - | $800.65M(+1.6%) |
| Mar 2023 | - | $788.31M(+4.8%) |
| Dec 2022 | $752.39M(+17.0%) | $752.39M(-2.4%) |
| Sep 2022 | - | $770.78M(+3.1%) |
| Jun 2022 | - | $747.61M(+7.1%) |
| Mar 2022 | - | $697.84M(+8.5%) |
| Dec 2021 | $642.88M(+4.1%) | $642.88M(-2.7%) |
| Sep 2021 | - | $660.45M(+2.6%) |
| Jun 2021 | - | $644.03M(+5.5%) |
| Mar 2021 | - | $610.57M(-1.2%) |
| Dec 2020 | $617.74M(+20.2%) | $617.74M(+8.0%) |
| Sep 2020 | - | $572.06M(+7.4%) |
| Jun 2020 | - | $532.53M(-1.8%) |
| Mar 2020 | - | $542.39M(+5.5%) |
| Dec 2019 | $514.03M(+8.8%) | $514.03M(-1.9%) |
| Sep 2019 | - | $524.07M(-3.9%) |
| Jun 2019 | - | $545.15M(+10.0%) |
| Mar 2019 | - | $495.50M(+4.9%) |
| Dec 2018 | $472.25M(+9.8%) | $472.25M(-3.1%) |
| Sep 2018 | - | $487.34M(+1.8%) |
| Jun 2018 | - | $478.74M(+8.8%) |
| Mar 2018 | - | $440.11M(+2.3%) |
| Dec 2017 | $430.02M(+18.1%) | $430.02M(+1.8%) |
| Sep 2017 | - | $422.33M(+5.4%) |
| Jun 2017 | - | $400.75M(+3.8%) |
| Mar 2017 | - | $386.09M(+6.1%) |
| Dec 2016 | $364.05M(+34.8%) | $364.05M(+0.3%) |
| Sep 2016 | - | $362.80M(+4.3%) |
| Jun 2016 | - | $347.84M(+20.1%) |
| Mar 2016 | - | $289.56M(+7.2%) |
| Dec 2015 | $270.07M(+4.7%) | $270.07M(-8.3%) |
| Sep 2015 | - | $294.46M(+4.2%) |
| Jun 2015 | - | $282.58M(+4.4%) |
| Mar 2015 | - | $270.61M(+4.9%) |
| Dec 2014 | $257.99M(+16.9%) | $257.99M(-6.2%) |
| Sep 2014 | - | $275.02M(+0.2%) |
| Jun 2014 | - | $274.50M(+14.4%) |
| Mar 2014 | - | $240.00M(+8.8%) |
| Dec 2013 | $220.63M(+8.7%) | $220.63M(-1.6%) |
| Sep 2013 | - | $224.27M(+0.1%) |
| Jun 2013 | - | $224.03M(+4.9%) |
| Mar 2013 | - | $213.54M(+5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $203.00M(+9.8%) | $203.00M(-5.9%) |
| Sep 2012 | - | $215.62M(+3.6%) |
| Jun 2012 | - | $208.05M(+1.0%) |
| Mar 2012 | - | $205.89M(+11.4%) |
| Dec 2011 | $184.81M(-4.2%) | $184.81M(-8.7%) |
| Sep 2011 | - | $202.38M(-4.7%) |
| Jun 2011 | - | $212.42M(-1.3%) |
| Mar 2011 | - | $215.30M(+11.6%) |
| Dec 2010 | $192.97M(-2.0%) | $192.97M(-11.0%) |
| Sep 2010 | - | $216.74M(-0.9%) |
| Jun 2010 | - | $218.69M(-0.4%) |
| Mar 2010 | - | $219.68M(+11.5%) |
| Dec 2009 | $196.95M(-6.3%) | $196.95M(-7.5%) |
| Sep 2009 | - | $212.87M(+1.4%) |
| Jun 2009 | - | $209.89M(-0.6%) |
| Mar 2009 | - | $211.09M(+0.4%) |
| Dec 2008 | $210.21M(-1.7%) | $210.21M(-11.4%) |
| Sep 2008 | - | $237.27M(-1.1%) |
| Jun 2008 | - | $240.01M(+0.3%) |
| Mar 2008 | - | $239.38M(+11.9%) |
| Dec 2007 | $213.91M(+36.8%) | $213.91M(-7.8%) |
| Sep 2007 | - | $232.04M(+1.5%) |
| Jun 2007 | - | $228.62M(+8.8%) |
| Mar 2007 | - | $210.17M(+3.7%) |
| Dec 2006 | $156.41M(+17.2%) | $202.66M(+9.4%) |
| Sep 2006 | - | $185.28M(+4.3%) |
| Jun 2006 | - | $177.56M(-11.7%) |
| Mar 2006 | - | $201.07M(+17.4%) |
| Dec 2005 | $133.44M(-33.9%) | $171.26M(-18.5%) |
| Sep 2005 | - | $210.16M(-0.1%) |
| Jun 2005 | - | $210.31M(+2.6%) |
| Mar 2005 | - | $204.91M(+1.5%) |
| Dec 2004 | $201.79M(+81.0%) | $201.79M(+56.9%) |
| Sep 2004 | - | $128.60M(+2.9%) |
| Jun 2004 | - | $124.98M(+4.2%) |
| Mar 2004 | - | $119.92M(+7.5%) |
| Dec 2003 | $111.51M(+18.3%) | $111.51M(+5.5%) |
| Sep 2003 | - | $105.65M(-0.8%) |
| Jun 2003 | - | $106.47M(+0.6%) |
| Mar 2003 | - | $105.81M(+12.3%) |
| Dec 2002 | $94.25M(-4.3%) | $94.25M(-4.5%) |
| Sep 2002 | - | $98.72M(-1.1%) |
| Jun 2002 | - | $99.83M(-5.0%) |
| Mar 2002 | - | $105.13M(+6.8%) |
| Dec 2001 | $98.48M(+114.3%) | $98.48M(+0.6%) |
| Sep 2001 | - | $97.94M(+12.2%) |
| Jun 2001 | - | $87.27M(+11.5%) |
| Mar 2001 | - | $78.30M(+70.4%) |
| Dec 2000 | $45.95M(+26.6%) | $45.95M |
| Dec 1999 | $36.29M(+11.8%) | - |
| Dec 1998 | $32.47M | - |
FAQ
- What is Charles River Laboratories International, Inc. annual accounts receivable?
- What is the all time high annual accounts receivable for Charles River Laboratories International, Inc.?
- What is Charles River Laboratories International, Inc. annual accounts receivable year-on-year change?
- What is Charles River Laboratories International, Inc. quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Charles River Laboratories International, Inc.?
- What is Charles River Laboratories International, Inc. quarterly accounts receivable year-on-year change?
What is Charles River Laboratories International, Inc. annual accounts receivable?
The current annual accounts receivable of CRL is $720.91M
What is the all time high annual accounts receivable for Charles River Laboratories International, Inc.?
Charles River Laboratories International, Inc. all-time high annual accounts receivable is $780.38M
What is Charles River Laboratories International, Inc. annual accounts receivable year-on-year change?
Over the past year, CRL annual accounts receivable has changed by -$59.46M (-7.62%)
What is Charles River Laboratories International, Inc. quarterly accounts receivable?
The current quarterly accounts receivable of CRL is $767.57M
What is the all time high quarterly accounts receivable for Charles River Laboratories International, Inc.?
Charles River Laboratories International, Inc. all-time high quarterly accounts receivable is $800.65M
What is Charles River Laboratories International, Inc. quarterly accounts receivable year-on-year change?
Over the past year, CRL quarterly accounts receivable has changed by +$5.35M (+0.70%)